Clinical Trials Transparency: Where Are We Today?
Epidemiology Unit, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid, Madrid, Spain. Electronic address: [email protected]
- Published Article
Trends in cancer
- Publication Date
Jan 01, 2018
To prevent reporting bias, policies and regulations mandating trial prospective registration and disclosure of results have been implemented since 2005. To achieve full trial transparency, open access to participants' deidentified data policies have been issued. Funders and journals have made critical decisions on these requirements in 2017 that will impact the current scenario. Copyright © 2017 Elsevier Inc. All rights reserved.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 10/20/2019 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/29413417